TABLE 1.
Analyte | Panther Fusion |
eSensor |
Lyrac |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
PPAa |
NPAb |
PPAa |
NPAb |
PPAa |
NPAb |
|||||||
No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | No. positive/no. consensus positive | % (95% CI) | |
Flu A | 33/33 | 100 (89.6–100) | 362/362 | 100 (98.9–100) | 33/33 | 100 (89.6–100) | 362/363 | 99.7 (98.4–100) | 33/33 | 100 (89.6–100) | 362/362 | 100 (98.9–100) |
Flu B | 18/18 | 100 (82.4–100) | 377/377 | 100 (98.9–100) | 18/18 | 100 (82.4–100) | 377/377 | 100 (98.9–100) | 15/18 | 83.3 (60.8–94.2) | 377/377 | 100 (98.9–100) |
RSV | 48/48 | 100 (92.6–100) | 347/347 | 100 (98.9–100) | 48/48 | 100 (92.6–100) | 347/349 | 99.4 (97.9–99.8) | 36/48 | 75 (61.2–85.1) | 347/347 | 100 (98.9–100) |
Para 1–3 | 22/22 | 100 (85.1–100) | 373/374 | 99.7 (98.5–100) | 22/22 | 100 (85.1–100) | 373/375 | 99.5 (98.1–99.9) | 15/22 | 68.2 (47.3–83.6) | 373/373 | 100 (98.9–100) |
hMPV | 24/24 | 100 (86.2–100) | 371/375 | 98.9 (97.3–99.6) | 24/24 | 100 (86.2–100) | 371/372 | 99.7 (98.5–100) | 19/24 | 79.2 (59.5–90.8) | 371/371 | 100 (98.9–100) |
Adeno | 5/5 | 100 (56.6–100) | 390/390 | 100 (99–100) | 5/5 | 100 (56.6–100) | 390/391 | 99.7 (98.6–100) | 5/5 | 100 (56.6–100) | 390/390 | 100 (99–100) |
RV | 91/91 | 100 (96–100) | 304/309 | 98.4 (96.2–99.3) | 91/91 | 100 (96–100) | 304/325 | 93.5 (89.7–95.4) |
PPA, positive percent agreement.
NPA, negative percent agreement.
The Lyra assay does not test for the RV target.